This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Interestingly, as of January 12, 2023, Moderna has listed 10 patents covering Spikevax (its mRNA vaccine) on its website.
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. This pattern has had lethal consequences during the COVID-19 pandemic, harming efforts to advance global solidarity.
Yet when COVID-19 – the greatest health emergency in a century – devastated the world, the Siracusa Principles seemed unequal to the task – too narrow, including with their remit limited to civil and political rights, not sufficiently specific, and above all, without sufficient accountability.
Nevertheless, the onset of the COVID-19 pandemic caused a major panic in the country’s legal system and judiciary. Additionally, the Government declared COVID-19 a “ formidable disease ” under the Public Health Act on April 1, 2020.
Some COVID-19vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. This problem is not new in the biotechnology sector.
While receiving significant global traction and acceptance since their publication in 1985, the Siracusa Principles, the authors argue, proved to be simply “unequal to the task” of guiding States’ conduct in the context of COVID-19 because they are “unable to speak in any significant detail to the particular concerns of public health crises.”
The COVID-19 pandemic has raised unprecedented challenges for the global health framework and its long-term consequences are not yet in full sight. This was witnessed in the early stages of COVID-19, when Vietnam and Taiwan decided to adopt stringent measures well before the end of January. By Ilja Richard Pavone.
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19vaccines. Impact of the judgment: what have records disclosed shown?
Despite these experiences, Kenya failed take a human rights-based approach to responding to COVID-19, as was also the case in many other countries. Deepening this challenge, the enactment of new legislation during the COVID-19 pandemic — and especially in its early stages — was near impossible.
By Anita Gholami The Parliamentary Assembly of the Council of Europe, which brings together parliamentarians from 46 member States, has been a vigilant guardian of respect for the European Convention on Human Rights and other international standards throughout the COVID-19 pandemic.
By Anne Kjersti Befring and Cecilia Marcela Bailliet Introduction The COVID-19 pandemic posed a grave threat to humanity and revealed the need for a new approach to improve transnational cooperation within the global health system and new perspectives on solidarity addressing the cross-border spread of infection and distribution of vaccines.
The COVID-19 pandemic has amplified this legal challenge and highlighted the need to treat liability as a key legal preparedness issue. The demand for liability protections reemerged in 2009 during H1N1, in attenuated form during the 2014-15 West Africa Ebola public health emergency, and, prominently, during COVID-19.
Reports by the Global Initiative for Economic, Social and Cultural Rights (GI-ESCR) and partners showed that this situation was a breeding ground for discrimination and inequality in accessing health care services during COVID-19.
Over the course of the COVID-19 pandemic, the accompanying infodemic gained visibility through the widespread use of digital resources, platforms and tools to support a range of social interactions, activities, and pandemic countermeasures.
By Roojin Habibi, Timothy Fish Hodgson, and Alicia Ely Yamin Today, as the world transitions from living in the grips of a novel coronavirus to living with an entrenched, widespread infectious disease known as COVID-19, global appreciation for the human rights implications of public health crises are once again rapidly fading from view.
COVID-19 and the U.S. health system The COVID-19 pandemic had devastating effects on the United States, and brought these long standing health inequities and policy failures – from resource allocation to public health coordination – into the view of the general American public.
The vulnerability of the child in global health emergencies At the height of the COVID-19 pandemic, 194 countries and territories shut their schools nationally , affecting the right to education of more than a billion children. should account for the best interests of the child as a primary consideration.
By Silvia Serrano Guzmán On July 4, 2023 the Constitutional Court of Colombia handed down a landmark decision on one of the most difficult dilemmas faced during the COVID-19 pandemic: the rationing of intensive care in situations of scarcity.
The world has been in urgent need of COVID-19vaccines, treatments, and diagnostic tools. Here’s a look at what we’ve learned from COVID-19 era regulatory practices in clinical development. This first came for COVID-19 test kits and treatments aimed at minimizing symptoms and shortening disease duration.
Despite pediatric COVID-19vaccine availability, many youth remain unvaccinated , and are thus at higher risk of life-altering outcomes as a result of contracting COVID-19. [1]. Youth in the foster care system and those who are justice-involved face additional challenges during the ongoing COVID-19 pandemic.
By María Natalia Echegoyemberry and Francisco Verbic This article looks at the COVID-19 pandemic response in Argentina, with a particular focus on the judicial control of public health policies. We focus on a case in Argentina where a federal judge ordered the suspension of the campaign for pediatric vaccination against COVID-19.
So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19vaccine that was used to control the recent pandemic. The suit “relates to” – at least – “the. . .
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content